Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doron Lipson

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Plos One|March 20, 2010
A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotypeYosef Buganim, Ido Goldstein, Doron Lipson, et al.
Case Reports in Oncology|September 19, 2014
Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown PrimaryNorma A Palma, Siraj M Ali, Jamie O'Connor, et al.
Clinical Breast Cancer|November 9, 2013
Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinibSiraj M Ali, R Kathy Alpaugh, Jamie K Buell, et al.
Science (New York, N.Y.)|January 15, 2011
Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancersDavid T Ting, Doron Lipson, Suchismita Paul, et al.
Archives of Pathology & Laboratory Medicine|May 1, 2015
Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment optionsJeffrey S Ross, Sunil Badve, Kai Wang, et al.
Nature Biotechnology|September 15, 2022
Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencingSean K Simmons, Gila Lithwick-Yanai, Xian Adiconis, et al.
British Journal of Haematology|June 14, 2016
Unique genomic features in adolescent and young adult, as compared to older adult, non-Hodgkin lymphoma and potential therapeutic targetsAdrienne Johnson, Deborah Morosini, Jo-Anne Vergilio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancerNir Peled, Gary Palmer, Fred R Hirsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibitionKatherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.
The Oncologist|September 4, 2015
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and DifferencesKai Wang, Adrienne Johnson, Siraj M Ali, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Plos One|March 20, 2010
A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotypeYosef Buganim, Ido Goldstein, Doron Lipson, et al.
Case Reports in Oncology|September 19, 2014
Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown PrimaryNorma A Palma, Siraj M Ali, Jamie O'Connor, et al.
Clinical Breast Cancer|November 9, 2013
Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinibSiraj M Ali, R Kathy Alpaugh, Jamie K Buell, et al.
Science (New York, N.Y.)|January 15, 2011
Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancersDavid T Ting, Doron Lipson, Suchismita Paul, et al.
Archives of Pathology & Laboratory Medicine|May 1, 2015
Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment optionsJeffrey S Ross, Sunil Badve, Kai Wang, et al.
Nature Biotechnology|September 15, 2022
Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencingSean K Simmons, Gila Lithwick-Yanai, Xian Adiconis, et al.
British Journal of Haematology|June 14, 2016
Unique genomic features in adolescent and young adult, as compared to older adult, non-Hodgkin lymphoma and potential therapeutic targetsAdrienne Johnson, Deborah Morosini, Jo-Anne Vergilio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancerNir Peled, Gary Palmer, Fred R Hirsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibitionKatherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.
The Oncologist|September 4, 2015
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and DifferencesKai Wang, Adrienne Johnson, Siraj M Ali, et al.
Pageof 10